lamivudine

Generic: lamivudine

Labeler: ingenus pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lamivudine
Generic Name lamivudine
Labeler ingenus pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lamivudine 150 mg/1

Manufacturer
Ingenus Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 50742-623
Product ID 50742-623_723a8db6-baa2-47f7-a352-0ed4c25a184e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206974
Listing Expiration 2026-12-31
Marketing Start 2017-02-01

Pharmacologic Class

Established (EPC)
hepatitis b virus nucleoside analog reverse transcriptase inhibitor [epc] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50742623
Hyphenated Format 50742-623

Supplemental Identifiers

RxCUI
199147 349491
UPC
0350742623600
UNII
2T8Q726O95
NUI
N0000175656 N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamivudine (source: ndc)
Generic Name lamivudine (source: ndc)
Application Number ANDA206974 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)
source: ndc

Packages (1)

50742-623-60 60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)

Ingredients (1)

lamivudine (150 mg/1)

Linked Drug Pages (1)

Lamivudine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "723a8db6-baa2-47f7-a352-0ed4c25a184e", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "upc": ["0350742623600"], "unii": ["2T8Q726O95"], "rxcui": ["199147", "349491"], "spl_set_id": ["47f8be59-178c-4bad-96a4-a5c82784f308"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)", "package_ndc": "50742-623-60", "marketing_start_date": "20170201"}], "brand_name": "Lamivudine", "product_id": "50742-623_723a8db6-baa2-47f7-a352-0ed4c25a184e", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "50742-623", "generic_name": "Lamivudine", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}], "application_number": "ANDA206974", "marketing_category": "ANDA", "marketing_start_date": "20170201", "listing_expiration_date": "20261231"}